FT001, FT-001, FT 001, Epigenetic Reader Domain, EpigeneticReaderDomain, BET bromodomain
FT001 is a potent, selective, and orally bioavailable BET bromodomain inhibitor with antitumor activity. It suppresses MYC expression (IC50 = 0.46 µM) and demonstrates potent antiproliferative effects against MV-4-11 cells, along with significant MYC mRNA suppression in both in vitro and in vivo models.
Molekulargewicht:
467.58
Reinheit:
>99.99% (May vary between batches)
CAS Nummer:
[1778655-51-8]
Formel:
C25H29N3O4S
Target-Kategorie:
Epigenetic Reader Domain
Anwendungsbeschreibung:
Solubility: DMSO:45 mg/mL (96.24 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten